M&A

Kite chief Arie Belldegrun up for $600M-plus payday from Gilead buyout
Fierce Pharma
Thu, 08/31/17 - 10:05 pm
Kite Pharma
Gilead Sciences
M&A
executive pay
Arie Belldegrun
Biotech: Back In Vogue
Barron's
Thu, 08/31/17 - 10:52 am
biotech
biotech stocks
Gilead Sciences
M&A
Kite Pharma
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
Thu, 08/31/17 - 09:28 am
AstraZeneca
Daiichi Sankyo
M&A
Has Gilead Sciences' Big Bounce Begun With the Kite Pharma Buyout?
Motley Fool
Wed, 08/30/17 - 10:04 am
Gilead Sciences
CAR-T
Kite Pharma
M&A
Get Ready for More Acquisitions by Gilead Sciences
Motley Fool
Wed, 08/30/17 - 09:36 am
Gilead Sciences
M&A
Kite Pharma
Ziopharm
How will Gilead price CAR-T? With Kite buy, the top biotech joins Novartis in spotlight
Fierce Pharma
Tue, 08/29/17 - 09:07 pm
Gilead Sciences
Kite Pharma
CAR-T
drug pricing
M&A
Here's What Else Gilead Sciences Gets by Buying Kite Pharma
Motley Fool
Tue, 08/29/17 - 10:01 am
Gilead Sciences
Kite Pharma
M&A
CAR-T
TCR-targeted drugs
To Be More Than a Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles
Xconomy
Tue, 08/29/17 - 01:12 pm
Gilead Sciences
Kite Pharma
M&A
CAR-T
5 Reasons The Gilead-Kite Acquisition Might Work
Seeking Alpha
Mon, 08/28/17 - 10:47 pm
Gilead Sciences
M&A
Kite Pharma
CAR-T
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Motley Fool
Mon, 08/28/17 - 10:26 pm
Bluebird Bio
Juno Therapeutics
Gilead Sciences
Kite Pharma
CAR-T
M&A
Gilead agrees to buy Kite Pharma, leaping into CAR-T cancer therapy
Stat
Mon, 08/28/17 - 10:04 am
Gilead Sciences
Kite Pharma
CAR-T
M&A
axi-cel
Regenxbio to buy battered Dimension for gene therapies
Fierce Biotech
Mon, 08/28/17 - 09:38 am
Regenxbio
Dimension Therapeutics
gene therapies
M&A
CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
Endpoints
Mon, 08/28/17 - 09:29 am
CSL
Calimmune
M&A
stem cells
Novartis returns to the discount aisle, buys Xoma’s failed PhIII drug for $31M
Endpoints
Fri, 08/25/17 - 09:53 am
Novartis
Xoma
M&A
gevokizumab
cardiovascular disease
Bidders line up for Teva's women's health unit in potential $2B sale
Fierce Pharma
Tue, 08/22/17 - 06:50 pm
Teva Pharmaceutical
M&A
Women's Health
5 Important Healthcare Predictions For 2018
Forbes
Tue, 08/22/17 - 09:59 am
specialty diseases
M&A
generics
technology
Asia
Stada successfully acquired for €5.3bn
GoInPharma
Sat, 08/19/17 - 10:36 am
Stada
Germany
M&A
Bain Capital
Cinven
Eli Lilly: Can Sales Grow Without M&A?
Barron's
Sat, 08/19/17 - 10:31 am
Eli Lilly
M&A
Biotech M&A barely showing sign of a pulse so far in 2017
Endpoints
Fri, 08/18/17 - 12:16 pm
biotech
M&A
Why Gilead Sciences Might Not Make an Oncology Acquisition
Motley Fool
Tue, 08/15/17 - 08:16 pm
Gilead Sciences
M&A
oncology

Pages